FIA
CAPR icon

Foundations Investment Advisors’s Capricor Therapeutics CAPR Stock Holding History

Foundations Investment Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
60,010
+6,006
+11% +$182K 0.01% 486
2026
Q1 		$1.64M Buy
+54,004
New +$1.44M 0.02% 411

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Foundations Investment Advisors's CAPR Position: Q2 2026 in Review

Foundations Investment Advisors increased its Capricor Therapeutics (CAPR) stake by 11% in Q2 2026, buying an estimated $182K and bringing the position to 60,010 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #486.

Foundations Investment Advisors first reported a position in CAPR in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.64M in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Foundations Investment Advisors held 60,010 shares of Capricor Therapeutics worth $1.45M as of Q2 2026.
  • Foundations Investment Advisors bought 6,006 Capricor Therapeutics shares in Q2 2026, an estimated $182K.
  • Capricor Therapeutics made up 0.01% of Foundations Investment Advisors's portfolio in Q2 2026, its #486 holding.
  • Foundations Investment Advisors first reported a position in Capricor Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Foundations Investment Advisors's Capricor Therapeutics position peaked at $1.64M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.